Search research articles
Contact Us
Filters
Showing results (51-60 of 137) with videos related to
Page
of 14
Sort By:
Clinical Lymphoma, Myeloma & Leukemia
|
July 16, 2019
Symptom Burden and Blood Counts in Patients With Polycythemia Vera in the United States: An Analysis From the REVEAL Study
Michael R Grunwald, John M Burke, David J Kuter, et al.
Blood Advances
|
March 17, 2023
Consensus recommendations on peripheral blood smear review: defining curricular standards and fellow competency
Matthew L Chase, Reed Drews, Marc S Zumberg, et al.
Advances in Therapy
|
July 11, 2024
Momelotinib versus Continued Ruxolitinib or Best Available Therapy in JAK Inhibitor-Experienced Patients with Myelofibrosis and Anemia: Subgroup Analysis of SIMPLIFY-2
Claire N Harrison, Alessandro M Vannucchi, Christian Recher, et al.
The Oncologist
|
April 29, 2023
Patterns of Diagnostic Evaluation and Determinants of Treatment in Older Patients With Non-transfusion Dependent Myelodysplastic Syndromes
Sudipto Mukherjee, Weichuan Dong, Nicholas K Schiltz, et al.
Haematologica
|
January 5, 2023
Long-term treatment with pacritinib on a compassionate use basis in patients with advanced myelofibrosis
Claire Harrison, Abdulraheem Yacoub, Bart Scott, et al.
Hematology/Oncology and Stem Cell Therapy
|
December 10, 2020
Survival following relapse after allogeneic hematopoietic cell transplantation for acute leukemia and myelodysplastic syndromes in the contemporary era
Sanghee Hong, Lisa Rybicki, Donna Corrigan, et al.
Bone Marrow Transplantation
|
January 19, 2019
Mutation clonal burden and allogeneic hematopoietic cell transplantation outcomes in acute myeloid leukemia and myelodysplastic syndromes
Betty K Hamilton, Lisa Rybicki, Casandra Hirsch, et al.
Leukemia & Lymphoma
|
December 30, 2020
Outcomes and factors impacting use of axicabtagene ciloleucel in patients with relapsed or refractory large B-cell lymphoma: results from an intention-to-treat analysis
Agrima Mian, Wei Wei, Allison M Winter, et al.
Leukemia Research
|
April 29, 2019
Corrigendum to "Phase 1/2 trial of glasdegib in patients with primary or secondary myelofibrosis previously treated with ruxolitinib" [Leukemia Res. 79 (2019) 38-44]
Aaron T Gerds, Tetsuzo Tauchi, Ellen Ritchie, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
February 18, 2020
Treatment Patterns and Blood Counts in Patients With Polycythemia Vera Treated With Hydroxyurea in the United States: An Analysis From the REVEAL Study
Michael R Grunwald, David J Kuter, Ivy Altomare, et al.
Page
of 14
Search research articles
Search
Showing results (51-60 of 137) with videos related to
Sort By:
Page
of 14
Clinical Lymphoma, Myeloma & Leukemia
|
July 16, 2019
Symptom Burden and Blood Counts in Patients With Polycythemia Vera in the United States: An Analysis From the REVEAL Study
Michael R Grunwald, John M Burke, David J Kuter, et al.
Blood Advances
|
March 17, 2023
Consensus recommendations on peripheral blood smear review: defining curricular standards and fellow competency
Matthew L Chase, Reed Drews, Marc S Zumberg, et al.
Advances in Therapy
|
July 11, 2024
Momelotinib versus Continued Ruxolitinib or Best Available Therapy in JAK Inhibitor-Experienced Patients with Myelofibrosis and Anemia: Subgroup Analysis of SIMPLIFY-2
Claire N Harrison, Alessandro M Vannucchi, Christian Recher, et al.
The Oncologist
|
April 29, 2023
Patterns of Diagnostic Evaluation and Determinants of Treatment in Older Patients With Non-transfusion Dependent Myelodysplastic Syndromes
Sudipto Mukherjee, Weichuan Dong, Nicholas K Schiltz, et al.
Haematologica
|
January 5, 2023
Long-term treatment with pacritinib on a compassionate use basis in patients with advanced myelofibrosis
Claire Harrison, Abdulraheem Yacoub, Bart Scott, et al.
Hematology/Oncology and Stem Cell Therapy
|
December 10, 2020
Survival following relapse after allogeneic hematopoietic cell transplantation for acute leukemia and myelodysplastic syndromes in the contemporary era
Sanghee Hong, Lisa Rybicki, Donna Corrigan, et al.
Bone Marrow Transplantation
|
January 19, 2019
Mutation clonal burden and allogeneic hematopoietic cell transplantation outcomes in acute myeloid leukemia and myelodysplastic syndromes
Betty K Hamilton, Lisa Rybicki, Casandra Hirsch, et al.
Leukemia & Lymphoma
|
December 30, 2020
Outcomes and factors impacting use of axicabtagene ciloleucel in patients with relapsed or refractory large B-cell lymphoma: results from an intention-to-treat analysis
Agrima Mian, Wei Wei, Allison M Winter, et al.
Leukemia Research
|
April 29, 2019
Corrigendum to "Phase 1/2 trial of glasdegib in patients with primary or secondary myelofibrosis previously treated with ruxolitinib" [Leukemia Res. 79 (2019) 38-44]
Aaron T Gerds, Tetsuzo Tauchi, Ellen Ritchie, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
February 18, 2020
Treatment Patterns and Blood Counts in Patients With Polycythemia Vera Treated With Hydroxyurea in the United States: An Analysis From the REVEAL Study
Michael R Grunwald, David J Kuter, Ivy Altomare, et al.
Page
of 14